Stem cell engineering breakthrough paves way for next-generation living drugs

UBC research associate Dr. Ross Jones in the lab where they are working to develop cell-based therapies from stem cells.
Photo Credit: Phillip Chin.

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a controlled laboratory setting.  

The findings, published today in Cell Stem Cell, overcome a major hurdle that has limited the development, affordability and large-scale manufacturing of cell therapies. The discovery could pave the way for more accessible and effective off-the-shelf treatments for a wide range of conditions like cancer, infectious diseases, autoimmune disorders and more.   

“Engineered cell therapies are transforming modern medicine,” said co-senior author Dr. Peter Zandstra, professor and director of the UBC School of Biomedical Engineering. “This study addresses one of the biggest challenges in making these lifesaving treatments accessible to more people, showing for the first time a reliable and scalable way to grow multiple immune cell types.”  

AI model predicts disease risk while you sleep

SleepFM utilizes diverse physiological data streams, highlighting the potential to improve disease forecasting and better understand health risks.
Image Credit: Scientific Frontline / AI generated (Gemini)

The first artificial intelligence model of its kind can predict more than 100 health conditions from one night’s sleep.

A poor night’s sleep portends a bleary-eyed next day, but it could also hint at diseases that will strike years down the road. A new artificial intelligence model developed by Stanford Medicine researchers and their colleagues can use physiological recordings from one night’s sleep to predict a person’s risk of developing more than 100 health conditions.

Known as SleepFM, the model was trained on nearly 600,000 hours of sleep data collected from 65,000 participants. The sleep data comes from polysomnography, a comprehensive sleep assessment that uses various sensors to record brain activity, heart activity, respiratory signals, leg movements, eye movements, and more.

International research breakthrough for remote Alzheimer’s testing

Photo Credit: Courtesy of University of Exeter

A groundbreaking international study has demonstrated that Alzheimer’s disease biomarkers can be accurately detected using simple finger-prick blood samples that can be collected at home and mailed to laboratories without refrigeration or prior processing. 

The research, led by US institute Banner Health working with the University of Exeter Medical School and supported by the National Institute for Health and Care Research (NIHR), published today in Nature Medicine. It represents the first large-scale validation of this accessible testing approach that removes geographic barriers and opens brain disease research to global populations without requiring specialized healthcare infrastructure. 

The DROP-AD project, conducted across seven European medical centers including the University of Gothenburg and University of Exeter, successfully tested 337 participants and proved that finger-prick blood collection can accurately measure key markers of Alzheimer’s pathology and brain damage. This breakthrough enables worldwide research participation by eliminating the logistical constraints that have historically limited biomarker studies to well-resourced medical facilities. 

Researchers find breast cancer drug boosts leukemia treatment

Jeffrey Tyner, Ph.D., and Melissa Stewart, Ph.D., led a team at OHSU that discovered a new drug combination that may help people with acute myeloid leukemia.
Photo Credit: OHSU/Christine Torres Hicks

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common frontline therapies.

In a study published in Cell Reports Medicine, researchers analyzed more than 300 acute myeloid leukemia, or AML, patient samples and found that pairing venetoclax, a standard AML drug, with palbociclib, a cell-cycle inhibitor currently approved for breast cancer, produced significantly stronger and more durable anti-leukemia activity than venetoclax alone. The findings were confirmed in human tissue samples as well as in mouse models carrying human leukemia cells.

“Of the 25 drug combinations tested, venetoclax plus palbociclib was the most effective. That really motivated us to dig deeper into why it works so well, and why it appears to overcome resistance seen with current therapy,” said Melissa Stewart, Ph.D., research assistant professor in the OHSU School of Medicine and Knight Cancer Institute and lead author of the study.

More than 20,000 Americans are diagnosed with AML each year, making it one of the most common types of leukemia — and one of the most aggressive.

Chew on this: Losing teeth weakens key memory hub in mouse brains

Mice that lost their molars showed significant memory decline despite receiving the same diet as controls, hinting at the impact of reduced chewing on brain health.
Illustration Credit: Rie Hatakeyama

Tooth loss doesn’t just make eating harder, it may also make thinking more challenging. A new study from Hiroshima University shows that aging mice missing their molars experience measurable cognitive decline, even when their nutrition remains perfectly intact.

“Tooth loss is common in aging populations, yet its direct neurological impact has remained unclear,” said Rie Hatakeyama, postdoctoral researcher at Hiroshima University’s (HU) Graduate School of Biomedical and Health Sciences and first author of the study. 

Menopause hormone therapy does not appear to impact dementia risk

Photo Credit: Vitaly Gariev

A major review of prior research has found no evidence that menopause hormone therapy either increases or decreases dementia risk in post-menopausal women, in a new study led by University College London researchers and supported by the University of Exeter. 

The findings, commissioned by the World Health Organization (WHO) and published in The Lancet Healthy Longevity, add much-needed clarity to a hotly debated topic, and reinforce current clinical guidance that menopause hormone therapy, also called hormone replacement therapy or HRT, should be guided by perceived benefits and risks and not for dementia prevention. 

Professor Chris Fox from the University of Exeter Medical School said: “The role of menopause hormone treatment and relationship to dementia is a worry for many women. But our state-of-the-art review indicates there is no evidence that menopause hormone treatment reduces or increases the risk of dementia. When deciding whether to take menopause hormone treatment, reducing one’s risk of dementia should not be part of that decision “ 

Restoring the healthy form of a protein could revive blood vessel growth in premature infants’ lungs

A blood vessel organoid.
Video Credit: Yunpei Zhang and Enbo Zhu, Mingxia Gu Lab

A UCLA-led research team has discovered a molecular switch that determines whether tiny blood vessels in premature infants’ lungs can regenerate after injury. A failure of this repair process is a hallmark of bronchopulmonary dysplasia, or BPD, a serious lung disease that affects babies born very early. It arises from a combination of premature birth, inflammation or infection, and exposure to the high levels of oxygen and breathing support that are necessary to keep these infants alive during a critical period of lung development.

The researchers found that in BPD, the blood vessel cells in the lungs begin producing a shortened, nonfunctional isoform — a version of a protein — called NTRK2, which has been extensively studied in the nervous system but not in the pulmonary vasculature. When this shortened isoform dominates, the lung cannot rebuild the delicate network of tiny blood vessels needed for healthy breathing.

Exposure to PFAS and PCBs linked to higher odds of MS

Aina Vaivade and Kim Kultima have measured the levels of common environmental pollutants in the blood of people with MS using a mass spectrometer (pictured).
Photo Credit: Tobias Sterner/Uppsala University

People who have been exposed to both PFAS and PCBs are more likely to be diagnosed with multiple sclerosis (MS). These new research findings are based on analyses of blood samples from more than 1,800 individuals in Sweden, one of the most comprehensive studies to date on the influence of chemical environmental exposure on the development of MS. 

Multiple sclerosis (MS) is an autoimmune disease in which both genetic and environmental factors can contribute to the risk of the disease. In the current study, researchers analyzed blood from individuals who had recently been diagnosed with MS to investigate concentrations of the common environmental contaminants PFAS and PCBs. 

Capturing the moment a cell shuts the door on free radicals

The moment a cell shuts the door on free radicals.
Illustration Credit: Catrin Jakobsson, Lund University

For the first time, researchers have been able to show how a cell closes the door to free radicals – small oxygen molecules that are sometimes needed, but that can also damage our cells. The study is published in Nature Communications and was led by Lund University. 

For our cells to function, they need to maintain a careful balance between beneficial and harmful oxygen molecules known as free radicals. One of the most important is hydrogen peroxide – the same substance found in disinfectants, but which our cells use in very small amounts to send important signals. However, in excessive concentrations, hydrogen peroxide can cause damage and even cell death.  

A platform to test new cancer treatments

Differentiated hepatic cells growing in a flask re-gain the appearance of cells present in liver.
Image Credit: © FAMOL, UNIGE

Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination therapies hold promise, their toxicity to healthy tissue remains a major hurdle. To anticipate these risks, researchers at the University of Geneva (UNIGE) have developed in vitro models of the kidneys, liver, and heart – three organs particularly sensitive to such therapies. This fast, animal-free approach paves the way for safer evaluation of new treatments. The findings are published in Biomedicine & Pharmacotherapy. 

Recent advances in immunotherapy, targeted therapies, and gene therapies have significantly improved survival rates for patients with cancer. However, over time, many tumors develop resistance to these treatments, undermining their effectiveness. This phenomenon, known as ‘acquired resistance’, has become one of the major challenges in oncology. 

Scientists identify small RNA molecule that regulates cholesterol and heart disease

Xiuchun Li is the first author of the research paper.
Photo Credit: UCR/Zhou lab

A team of researchers led by University of California, Riverside biomedical scientists has identified a small, previously overlooked small RNA molecule that plays a major role in controlling the body’s cholesterol production and the development of heart disease. The molecule, named tsRNA-Glu-CTC, could be a potential new target for future therapies aimed at lowering high cholesterol.

Using PANDORA-seq, a sequencing technology developed at UC Riverside, the scientists were able to detect hidden types of small RNAs in the liver, the organ central to cholesterol metabolism. They found that tsRNA-Glu-CTC is highly abundant in the liver (more than 65% of all detectable tsRNAs or tRNA-derived small RNAs) and responds directly to changes in cholesterol levels. The study was done in mice.

The research established a direct link between tsRNA-Glu-CTC and SREBP2 (Sterol Regulatory Element-Binding Protein 2), a key protein known as the “master regulator” of cholesterol production.

A delicate balance between growth hormone and stem cells

Andrei Chagin, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg.
Photo Credit: Magnus Gotander

Researchers at the University of Gothenburg can now demonstrate previously unexplained processes behind growth therapy. It involves hormonal mechanisms at the cellular level, with focus on a sensitive balance between stem cells and growth hormone. 

When children grow in length, it occurs from growth plates, a cartilage structure at both ends of the long bones found in the arms and legs. The growth plates contain special stem cells that continuously produce new cartilage cells, which are converted into bone tissue. 

In the case of growth disorders in children, with a height significantly below the average for their age and sex, injections of growth hormone are the most common treatment. In the development of growth hormone therapy, the University of Gothenburg has played a historically important role  

Previous research has shown that growth hormones act directly on the growth plate. However, it has been unclear which cells are targeted by growth hormones and how. 

Congenital muscle weakness: Muscles fail to regenerate

After a muscle injury, muscle stem cells (green) secrete laminin-α2 (magenta) into their surroundings to support their proliferation.
Image Credit: Timothy McGowan, Biozentrum, University of Basel

For more than two decades, researchers at the University of Basel have been investigating a severe form of muscular dystrophy in which muscles progressively degenerate. The research team has now discovered that the muscles’ ability to regenerate is also impaired. Future therapies should therefore aim not only to strengthen muscles but also to promote their regeneration. 

Roughly eight in every million children are born with a particularly severe form of muscle weakness known as LAMA2-related muscular dystrophy. In Switzerland, 18 cases are currently known. This rare hereditary disease is still incurable. The muscles of affected children gradually become weaker, including the respiratory musculature. In many cases, children do not reach adulthood. 

Possible therapeutic approach to treat diabetic nerve damage discovered

Longitudinal sections of two injured nerves with regenerating nerve fibers. Both specimens are from diabetic animals; in the lower image, the animal was treated with a peptide. Regeneration can be seen in the green-stained nerve fibers.
Image Credit: Dietmar Fischer / University of Cologne

Researchers have decoded the signaling pathway that inhibits nerve regeneration in diabetes and have developed a therapeutic peptide that could transform the treatment—and possibly even the prevention—of diabetic nerve damage. 

Nerve damage is one of the most common and burdensome complications of diabetes. Millions of patients worldwide suffer from pain, numbness, and restricted movement, largely because damaged nerve fibers do not regenerate sufficiently. The reasons for this are unclear. A research team led by Professor Dr Dietmar Fischer, Professor of Pharmacology at the University of Cologne’s Faculty of Medicine, and Director of the Center for Pharmacology at University Hospital Cologne, has now identified a central mechanism that explains limited regeneration in diabetes. Building on this, the researchers have developed a promising therapeutic approach that can be used to increase regeneration. Their findings were published in the ‘Science Translational Medicine’ journal under the title ‘Failure of nerve regeneration in mouse models of diabetes is caused by p35-mediated CDK5 hyperactivity’.

Seal milk more refined than breast milk

The Atlantic grey seal nurses its young for only 17 days. This means that the milk must be packed with good stuff to quickly prepare the seal pup for a tough life at sea. Researchers have analysed seal milk and discovered many new types of milk sugar.
Photo Credit: Patrick Pomeroy / contributing author

Researchers have discovered that milk from grey seals in the Atlantic Ocean may be more potent than breast milk. An analysis of seal milk found approximately 33 per cent more sugar molecules than in breast milk. Many of these sugars are unique and may pave the way for even better infant formulas for babies. 

During the 17 days that grey seal pups suckle, they need to get their digestive systems up and running and build up an immune system to protect them against diseases and other dangers they may encounter in the North Atlantic. It is reasonable to suspect that their mother's milk is extremely refined to accomplish this task. An international study with researchers from the University of Gothenburg and Chalmers University of Technology in Nature Communications shows that this is indeed the case. 

“Our analysis shows that grey seal milk is extraordinary. We identified 332 different sugar molecules, or sugars, compared to about 250 in breast milk. Two-thirds were completely unknown previously. Some of these molecules had a previously unseen size of 28 sugar units, which exceeds the largest known sugar units in breast milk, which are 18 units in size,” says Daniel Bojar, senior lecturer in bioinformatics at the University of Gothenburg. 

Why the "gut brain" plays a central role for allergies

This tissue section, taken from the intestine of a mouse unable to produce the neuropeptide VIP, clearly shows the striking frequency with which certain cell types occur on the intestine's surface. These include villous cells (red), mucus-producing goblet cells (yellow), Paneth cells (pink) and stem cells (green).
Image Credit: © Charité | Luisa Barleben

The intestinal nervous system, often referred to as the "gut brain", is essential in controlling digestion and maintaining the intestinal barrier. This protective layer, made up of the intestinal mucosa, immune cells and the microbiome, shields the body from the contents of the gut. Its effectiveness depends on the delicate balance among these components. If this balance is disrupted, inflammation, allergies, or chronic intestinal diseases can arise. The intestinal mucosa serves as the body’s primary defense against pathogens. While previous studies have shown that the intestinal nervous system is involved in immune responses in addition to digestion, its role in the development of intestinal epithelial cells has remained largely unclear until now. 

Blood protein profiles can predict mortality

Photo Credit: Akram Huseyn

Elevated levels of five proteins in our blood can help predict risk of mortality, a new study from the University of Surrey finds. Scientists believe the proteins (PLAUR, SERPINA3, CRIM1, DDR1 and LTBP2), that play key roles in the development of diseases such as cancer and inflammation, may also contribute to the risk of dying. Findings could help clinicians identify individuals most at risk from mortality and lead to earlier medical interventions.   

The study also discovered 392 proteins associated with an increased risk of death within a 5-year timeframe and a further 377 proteins associated with dying within 10 years, even when adjusting for health and lifestyle factors, such as smoking or pre-existing disease diagnoses. Proteins perform a wide range of essential functions in the body and are vital for growth, development, and the structure of every cell.  

New stem cell medium creates contracting canine heart muscle cells

Canine iPS cells cultured in a newly developed medium successfully differentiated into functional cardiomyocytes
Image Credit: Osaka Metropolitan University

Scientists obtained stem cells expressing cardiac muscle-specific genes and proteins. The cells displayed regular rhythmic contractions similar to a heart, confirming that they were functional cardiomyocyte cells.

In research, induced pluripotent stem (iPS) cells are derived from skin, urine, or blood samples and developed into other cells, like heart tissue, that researchers want to study. Because of the similarities between certain dog and human diseases, canine iPS cells have potential uses in regenerative medicine and drug discovery. 

Subverting Plasmids To Combat Antibiotic Resistance

Two types of plasmids, colored red and blue, form intricate patterns as they compete for dominance in a bacterial colony.
Image Credit: Fernando Rossine

Researchers in the Blavatnik Institute at Harvard Medical School have just opened a new window into understanding the development of antibiotic resistance in bacteria.

The work not only reveals principles of evolutionary biology but also suggests a new strategy to combat the antibiotic resistance crisis, which kills an estimated 1.3 million people per year worldwide.

Members of the labs of Michael Baym, associate professor of biomedical informatics, and Johan Paulsson, professor of systems biology, devised a way to track the evolution and spread of antibiotic resistance in individual bacteria by measuring competition among plasmids.

Microplastics hit male arteries hard

Changcheng Zhou Professor, Biomedical Sciences
Photo Credit: Courtesy of University of California, Riverside

A mouse study led by University of California, Riverside biomedical scientists suggests that everyday exposure to microplastics — tiny fragments shed from packaging, clothing, and countless plastic products — may accelerate the development of atherosclerosis, the artery-clogging process that leads to heart attacks and strokes. The harmful effects were seen only in male mice, offering new clues about how microplastics may affect cardiovascular health in humans.

“Our findings fit into a broader pattern seen in cardiovascular research, where males and females often respond differently,” said lead researcher Changcheng Zhou, a professor of biomedical sciences in the UCR School of Medicine. “Although the precise mechanism isn’t yet known, factors like sex chromosomes and hormones, particularly the protective effects of estrogen, may play a role.”